(FORR) Forrester Research - Ratings and Ratios

Forrester Research, Inc. is a global independent research and advisory firm that provides actionable insights to business and technology leaders. With operations spanning the United States, Europe, the United Kingdom, Canada, Asia Pacific, and beyond, the company is segmented into three primary revenue streams: Research, Consulting, and Events. The Research segment is a cornerstone, offering subscription-based services like Forrester Decisions, which guide leaders toward growth through customer-centric strategies. This includes delivering forward-thinking trends, predictive analytics, and comprehensive market forecasts, alongside curated best practices and benchmarking data.

The companys Consulting segment complements its Research offerings by providing tailored advisory services, including maturity assessments, strategic planning, vendor selection, and content marketing strategies. Meanwhile, the Events segment hosts conferences and summits focused on critical business-to-business topics, such as marketing, sales leadership, customer experience, and emerging technologies. Forresters sales model relies heavily on a direct sales force, ensuring personalized service and support to its clientele. With a history dating back to its incorporation in 1983 and headquartered in Cambridge, Massachusetts, Forrester has established itself as a venerable authority in its field.

Analyzing the provided and , we observe that Forrester Research, Inc. (NASDAQ:FORR) is currently trading at $10.17, slightly above its SMA20 and SMA50, indicating a potential short-term bullish trend. However, its SMA200 at $14.65 suggests a longer-term bearish outlook. The Average True Range (ATR) of 0.65, or 6.41%, signifies moderate volatility. Given its Market Cap of $191.71M USD and a Forward P/E of 7.89, the stock appears undervalued relative to its growth prospects. Notably, the negative RoE of -2.47% indicates recent operational challenges.

Forecasting Forresters stock performance involves integrating both technical and fundamental analyses. The recent uptick in price, coupled with a relatively low P/E Forward, may signal an attractive entry point for investors. However, the significant disparity between the current price and its 52W High of $20.19, alongside a negative RoE, warrants caution. A potential forecast could involve a gradual recovery toward its SMA200, assuming the company can navigate its operational inefficiencies and leverage its research and advisory strengths to drive growth. Thus, a short to medium-term target could be in the range of $12-$14, predicated on improved operational performance and market sentiment.